| |OCTOBER 20244India is witnessing a high growth in the market for Active Pharmaceutical Ingredients (APIs) which can be gauged from the factors that make it a strategic market in the global pharmaceutical market. The API sector is being pushed forward by the growth in demand for pharmaceuticals resulting from an increase in chronic diseases, an aging population, and an increased emphasis on healthcare. The Indian API market is poised to grow at a compound annual growth rate (CAGR) of more than 10 per cent over the next five years. This growth is one of the primary catalysts to it as the shift in pharmaceutical manufacturing practices is bringing many companies to produce APIs in house to avoid supply chain risk exposed during the pandemic. Investments in API manufacturing facilities across the country are on the rise due to this trend.Additionally, India's image as a global leader in generic medicines adds strength to its API market. The country constitutes an important part of the APIs which are used in generic drugs supplied worldwide, and there is still scope for the continuous expansion of export potential, thanks to ongoing collaborations between local companies and global pharma giants. This growth is also being supported by the Indian government which is promoting self-reliance through its Production-Linked Incentive (PLI) scheme to boost domestic manufacturing capabilities. These measures not only foster investment but also help develop the high value APIs for complex generics and biosimilars.Keeping tabs on this market, India Pharma Outlook has shortlisted the select few companies that have exhibited an unrelenting pursuit of excellence. By proving their dedication to fulfilling employee expectations and contributing to the market's evolution through their innovative disposition, these firms are blazing a trail. We look forward to receiving your feedback and suggestions. Sudhakar SinghManaging Editoreditor@indiapharmaoutlook.comEmpowering Wellness through InnovationVol 2 · Issue 5 -9 · October, 2024Publisher Alok ChaturvediEditor Sudhakar SinghAssistant Editor Roshan AktharEditorial TeamViswanathan AThiruamuthan T K GM - Media & Graphic Designing VisualizerPrabhu DuttaSenior DesignerRajesh R BDesignerV Hari PriyaSuanya BanerjeeAdvertising QueriesRahul KumarGM Sales & MarketingRavi kalgisales@indiapharmaoutlook.com Editorial Querieseditor@indiapharmaoutlook.comCirculation Manager Magendran PerumalMagazine Price is Rs. 150 per issuePrinted and Published By Alok Chaturvedi on behalf of Silicon Media Technologies Pvt. Ltd. and Printed at Precision Fototype Services at Sri Sabari Shopping Complex, 24 Residency Road Bangalore-560025 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Publisher Alok ChaturvediCopyright © 2024 Silicon Media Technologies Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.
< Page 3 | Page 5 >